Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 672

1.

Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.

Ray KK, Nicholls SJ, Buhr KA, Ginsberg HN, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Sweeney M, Schwartz GG; BETonMACE Investigators and Committees.

JAMA. 2020 Mar 27. doi: 10.1001/jama.2020.3308. [Epub ahead of print]

PMID:
32219359
2.

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease.

Chait A, Ginsberg HN, Vaisar T, Heinecke JW, Goldberg IJ, Bornfeldt KE.

Diabetes. 2020 Apr;69(4):508-516. doi: 10.2337/dbi19-0007.

PMID:
32198194
3.

Prioritizing Water Security in the Management of Vector-Borne Diseases: Lessons From Oaxaca, Mexico.

Akanda AS, Johnson K, Ginsberg HS, Couret J.

Geohealth. 2020 Mar 1;4(3):e2019GH000201. doi: 10.1029/2019GH000201. eCollection 2020 Mar.

4.

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN.

Eur Heart J. 2020 Feb 13. pii: ehz962. doi: 10.1093/eurheartj/ehz962. [Epub ahead of print] No abstract available.

PMID:
32052833
5.

Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.

Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, Byington R, Rimm EB, Sapp J, Gardner M, Cahill LE.

J Am Coll Cardiol. 2020 Feb 11;75(5):512-521. doi: 10.1016/j.jacc.2019.11.051.

PMID:
32029134
6.

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid.

Morieri ML, Shah HS, Sjaarda J, Lenzini PA, Campbell H, Motsinger-Reif AA, Gao H, Lovato L, Prudente S, Pandolfi A, Pezzolesi MG, Sigal RJ, Paré G, Marcovina SM, Rotroff DM, Patorno E, Mercuri L, Trischitta V, Chew EY, Kraft P, Buse JB, Wagner MJ, Cresci S, Gerstein HC, Ginsberg HN, Mychaleckyj JC, Doria A.

Diabetes. 2020 Apr;69(4):771-783. doi: 10.2337/db19-0973. Epub 2020 Jan 23.

PMID:
31974142
7.

Clinical review on triglycerides.

Laufs U, Parhofer KG, Ginsberg HN, Hegele RA.

Eur Heart J. 2020 Jan 1;41(1):99-109c. doi: 10.1093/eurheartj/ehz785.

8.

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.

Damask A, Steg PG, Schwartz GG, Szarek M, Hagström E, Badimon L, Chapman MJ, Boileau C, Tsimikas S, Ginsberg HN, Banerjee P, Manvelian G, Pordy R, Hess S, Overton JD, Lotta LA, Yancopoulos GD, Abecasis GR, Baras A, Paulding C; Regeneron Genetics Center and the ODYSSEY OUTCOMES Investigators.

Circulation. 2020 Feb 25;141(8):624-636. doi: 10.1161/CIRCULATIONAHA.119.044434. Epub 2019 Nov 11.

PMID:
31707832
9.

Local abundance of Ixodes scapularis in forests: Effects of environmental moisture, vegetation characteristics, and host abundance.

Ginsberg HS, Rulison EL, Miller JL, Pang G, Arsnoe IM, Hickling GJ, Ogden NH, LeBrun RA, Tsao JI.

Ticks Tick Borne Dis. 2020 Jan;11(1):101271. doi: 10.1016/j.ttbdis.2019.101271. Epub 2019 Sep 14.

PMID:
31677969
10.

Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 Years.

Chapman MJ, Ginsberg HN.

J Am Coll Cardiol. 2019 Oct 29;74(17):2147-2149. doi: 10.1016/j.jacc.2019.07.087. No abstract available.

PMID:
31648706
11.

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.

Hegele RA, Borén J, Ginsberg HN, Arca M, Averna M, Binder CJ, Calabresi L, Chapman MJ, Cuchel M, von Eckardstein A, Frikke-Schmidt R, Gaudet D, Hovingh GK, Kronenberg F, Lütjohann D, Parhofer KG, Raal FJ, Ray KK, Remaley AT, Stock JK, Stroes ES, Tokgözoğlu L, Catapano AL.

Lancet Diabetes Endocrinol. 2020 Jan;8(1):50-67. doi: 10.1016/S2213-8587(19)30264-5. Epub 2019 Sep 30. Review.

PMID:
31582260
12.

Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.

Ray KK, Nicholls SJ, Ginsberg HD, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Cummings JL, Sweeney M, Schwartz GG.

Am Heart J. 2019 Nov;217:72-83. doi: 10.1016/j.ahj.2019.08.001. Epub 2019 Aug 9.

PMID:
31520897
13.

Quantification of computational geometric congruence in surface-based registration for spinal intra-operative three-dimensional navigation.

Guha D, Jakubovic R, Leung MK, Ginsberg HJ, Fehlings MG, Mainprize TG, Yee A, Yang VXD.

PLoS One. 2019 Aug 26;14(8):e0207137. doi: 10.1371/journal.pone.0207137. eCollection 2019.

14.

Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?

Ginsberg HN, Reyes-Soffer G.

J Clin Invest. 2019 Oct 1;129(10):4074-4076. doi: 10.1172/JCI131333.

15.

Nuclear envelope-localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis.

Shin JY, Hernandez-Ono A, Fedotova T, Östlund C, Lee MJ, Gibeley SB, Liang CC, Dauer WT, Ginsberg HN, Worman HJ.

J Clin Invest. 2019 Aug 13;130:4885-4900. doi: 10.1172/JCI129769.

16.

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.

Vallejo-Vaz AJ, Ray KK, Ginsberg HN, Davidson MH, Eckel RH, Lee LV, Bessac L, Pordy R, Letierce A, Cannon CP.

Atherosclerosis. 2019 Sep;288:85-93. doi: 10.1016/j.atherosclerosis.2019.07.008. Epub 2019 Jul 12.

17.

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.

Ray KK, Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Louie MJ, Bujas-Bobanovic M, Minini P, Eckel RH, Cannon CP.

Atherosclerosis. 2019 Sep;288:194-202. doi: 10.1016/j.atherosclerosis.2019.06.896. Epub 2019 Jun 8.

18.

Life is complicated: so is apoCIII.

Reyes-Soffer G, Ginsberg HN.

J Lipid Res. 2019 Aug;60(8):1347-1349. doi: 10.1194/jlr.C119000214. Epub 2019 Jun 25. No abstract available.

PMID:
31239286
19.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

20.

Selective Trafficking of Fatty Acids in the Liver: Add Them2 to the List of Influencers.

Ginsberg HN.

Hepatology. 2019 Aug;70(2):462-464. doi: 10.1002/hep.30800. Epub 2019 Jul 15. No abstract available.

PMID:
31155742
21.
22.

A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction.

Afshar Bakooshli M, Lippmann ES, Mulcahy B, Iyer N, Nguyen CT, Tung K, Stewart BA, van den Dorpel H, Fuehrmann T, Shoichet M, Bigot A, Pegoraro E, Ahn H, Ginsberg H, Zhen M, Ashton RS, Gilbert PM.

Elife. 2019 May 14;8. pii: e44530. doi: 10.7554/eLife.44530.

23.

Diffuse idiopathic skeletal hyperostosis masquerading as asthma: case report.

Mithani K, Meng Y, Pinilla D, Thani N, Tung K, Leung R, Ginsberg HJ.

J Neurosurg Spine. 2019 Apr 26:1-4. doi: 10.3171/2019.2.SPINE181291. [Epub ahead of print]

PMID:
31026818
24.

Eastern Carpenter Bee (Hymenoptera: Apidae): Nest Structure, Nest Cell Provisions, and Trap Nest Acceptance in Rhode Island.

Tucker SK, Ginsberg HS, Alm SR.

Environ Entomol. 2019 Jun 7;48(3):702-710. doi: 10.1093/ee/nvz032.

PMID:
30980666
25.

Nonlinearities in transmission dynamics and efficient management of vector-borne pathogens.

Ginsberg HS, Couret J.

Ecol Appl. 2019 Jun;29(4):e01892. doi: 10.1002/eap.1892. Epub 2019 Apr 23.

PMID:
30929298
26.

Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales.

Woolman M, Kuzan-Fischer CM, Ferry I, Kiyota T, Luu B, Wu M, Munoz DG, Das S, Aman A, Taylor MD, Rutka JT, Ginsberg HJ, Zarrine-Afsar A.

Cancer Res. 2019 May 1;79(9):2426-2434. doi: 10.1158/0008-5472.CAN-18-3411. Epub 2019 Mar 19.

PMID:
30890619
27.

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.

Ginsberg HN, Tuomilehto J, Hovingh GK, Cariou B, Santos RD, Brown AS, Sanganalmath SK, Koren A, Thompson D, Raal FJ.

Cardiovasc Drugs Ther. 2019 Feb;33(1):69-76. doi: 10.1007/s10557-019-06852-6.

28.

Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.

Ference BA, Kastelein JJP, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, Laufs U, Oliver-Williams C, Wood AM, Butterworth AS, Di Angelantonio E, Danesh J, Nicholls SJ, Bhatt DL, Sabatine MS, Catapano AL.

JAMA. 2019 Jan 29;321(4):364-373. doi: 10.1001/jama.2018.20045.

29.

Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.

Reyes-Soffer G, Sztalryd C, Horenstein RB, Holleran S, Matveyenko A, Thomas T, Nandakumar R, Ngai C, Karmally W, Ginsberg HN, Ramakrishnan R, Pollin TI.

Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):63-72. doi: 10.1161/ATVBAHA.118.311476.

30.

Unilateral Lumbar Facet Dislocation: Case Report and Review of the Literature.

Cho N, Alkins R, Khan OH, Ginsberg H, Cusimano MD.

World Neurosurg. 2019 Mar;123:310-316. doi: 10.1016/j.wneu.2018.12.006. Epub 2018 Dec 18. Review.

PMID:
30576818
31.

Surgical treatment of a thoracic ventral intradural arachnoid cyst associated with syringomyelia: case report.

Haimoto S, Nishimura Y, Ginsberg HJ.

J Neurosurg Spine. 2018 Nov 23;30(2):193-197. doi: 10.3171/2018.8.SPINE18223.

PMID:
30497153
32.

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.

Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Eckel RH, Cannon CP, Lee LV, Bessac L, Pordy R, Letierce A, Ray KK.

J Am Heart Assoc. 2018 Sep 18;7(18):e009221. doi: 10.1161/JAHA.118.009221.

33.

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM.

Am Heart J. 2018 Dec;206:80-93. doi: 10.1016/j.ahj.2018.09.011. Epub 2018 Sep 29. Review.

34.

Intraoperative Ultrasound-Guided Posterior Cervical Laminectomy for Degenerative Cervical Myelopathy.

Schär RT, Wilson JR, Ginsberg HJ.

World Neurosurg. 2019 Jan;121:62-70. doi: 10.1016/j.wneu.2018.09.217. Epub 2018 Oct 9.

PMID:
30312813
35.

Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects.

Nandakumar R, Matveyenko A, Thomas T, Pavlyha M, Ngai C, Holleran S, Ramakrishnan R, Ginsberg HN, Karmally W, Marcovina SM, Reyes-Soffer G.

J Lipid Res. 2018 Dec;59(12):2397-2402. doi: 10.1194/jlr.P082834. Epub 2018 Oct 7.

36.

Correction: Monitoring for myelopathic progression with multiparametric quantitative MRI.

Martin AR, De Leener B, Cohen-Adad J, Kalsi-Ryan S, Cadotte DW, Wilson JR, Tetreault L, Nouri A, Crawley A, Mikulis DJ, Ginsberg H, Massicotte EM, Fehlings MG.

PLoS One. 2018 Sep 12;13(9):e0204082. doi: 10.1371/journal.pone.0204082. eCollection 2018.

37.

Progress and perspectives in plant sterol and plant stanol research.

Jones PJH, Shamloo M, MacKay DS, Rideout TC, Myrie SB, Plat J, Roullet JB, Baer DJ, Calkins KL, Davis HR, Barton Duell P, Ginsberg H, Gylling H, Jenkins D, Lütjohann D, Moghadasian M, Moreau RA, Mymin D, Ostlund RE Jr, Ras RT, Ochoa Reparaz J, Trautwein EA, Turley S, Vanmierlo T, Weingärtner O.

Nutr Rev. 2018 Oct 1;76(10):725-746. doi: 10.1093/nutrit/nuy032. Review.

38.

Evidence for Geographic Variation in Life-Cycle Processes Affecting Phenology of the Lyme Disease Vector Ixodes scapularis (Acari: Ixodidae) in the United States.

Ogden NH, Pang G, Ginsberg HS, Hickling GJ, Burke RL, Beati L, Tsao JI.

J Med Entomol. 2018 Oct 25;55(6):1386-1401. doi: 10.1093/jme/tjy104.

PMID:
29986046
39.

Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.

Ginsberg HN, Farnier M, Robinson JG, Cannon CP, Sattar N, Baccara-Dinet MT, Letierce A, Bujas-Bobanovic M, Louie MJ, Colhoun HM.

Diabetes Ther. 2018 Jun;9(3):1317-1334. doi: 10.1007/s13300-018-0439-8. Epub 2018 May 19.

40.

Reduction in surgical site infection with suprafascial intrawound application of vancomycin powder in instrumented posterior spinal fusion: a retrospective case-control study.

Haimoto S, Schär RT, Nishimura Y, Hara M, Wakabayashi T, Ginsberg HJ.

J Neurosurg Spine. 2018 Aug;29(2):193-198. doi: 10.3171/2017.12.SPINE17997. Epub 2018 May 4.

PMID:
29726801
41.

Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.

Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, März W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Stein EA, Stroes ES, Thompson PD, Tokgözoglu L, Vladutiu GD, Gencer B, Stock JK, Ginsberg HN, Chapman MJ; European Atherosclerosis Society Consensus Panel.

Eur Heart J. 2018 Jul 14;39(27):2526-2539. doi: 10.1093/eurheartj/ehy182. Review.

42.

Monitoring for myelopathic progression with multiparametric quantitative MRI.

Martin AR, De Leener B, Cohen-Adad J, Kalsi-Ryan S, Cadotte DW, Wilson JR, Tetreault L, Nouri A, Crawley A, Mikulis DJ, Ginsberg H, Massicotte EM, Fehlings MG.

PLoS One. 2018 Apr 17;13(4):e0195733. doi: 10.1371/journal.pone.0195733. eCollection 2018. Erratum in: PLoS One. 2018 Sep 12;13(9):e0204082.

43.

Can microstructural MRI detect subclinical tissue injury in subjects with asymptomatic cervical spinal cord compression? A prospective cohort study.

Martin AR, De Leener B, Cohen-Adad J, Cadotte DW, Nouri A, Wilson JR, Tetreault L, Crawley AP, Mikulis DJ, Ginsberg H, Fehlings MG.

BMJ Open. 2018 Apr 13;8(4):e019809. doi: 10.1136/bmjopen-2017-019809.

44.

γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor.

Kim K, Goldberg IJ, Graham MJ, Sundaram M, Bertaggia E, Lee SX, Qiang L, Haeusler RA, Metzger D, Chambon P, Yao Z, Ginsberg HN, Pajvani UB.

Cell Metab. 2018 Apr 3;27(4):816-827.e4. doi: 10.1016/j.cmet.2018.02.010. Epub 2018 Mar 22.

45.

Bioethics in Practice: The Ethics Surrounding the Use of Donor Milk.

Thibeau S, Ginsberg HG.

Ochsner J. 2018 Spring;18(1):17-19. No abstract available.

46.

Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials.

Henry RR, Müller-Wieland D, Taub PR, Bujas-Bobanovic M, Louie MJ, Letierce A, Ginsberg HN.

Diabetes Obes Metab. 2018 Jul;20(7):1632-1641. doi: 10.1111/dom.13273. Epub 2018 Mar 25.

47.

Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 Diabetes.

Koopal C, Visseren FLJ, Westerink J, van der Graaf Y, Ginsberg HN, Keech AC.

Diabetes Care. 2018 Jun;41(6):1244-1250. doi: 10.2337/dc17-0968. Epub 2018 Feb 22.

PMID:
29472432
48.

FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Lee SX, Heine M, Schlein C, Ramakrishnan R, Liu J, Belnavis G, Haimi I, Fischer AW, Ginsberg HN, Heeren J, Rinninger F, Haeusler RA.

J Clin Invest. 2018 Apr 2;128(4):1615-1626. doi: 10.1172/JCI94230. Epub 2018 Mar 19.

49.

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.

Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L.

J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014. Review.

50.

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.

Koska J, Saremi A, Howell S, Bahn G, De Courten B, Ginsberg H, Beisswenger PJ, Reaven PD; VADT Investigators.

Diabetes Care. 2018 Mar;41(3):570-576. doi: 10.2337/dc17-1740. Epub 2017 Dec 5.

Supplemental Content

Loading ...
Support Center